ARTICLE | Company News
Sequitur, P&G deal
May 26, 2003 7:00 AM UTC
The companies renewed and expanded their 2001 deal for Sequitur to conduct biological screens and supply antisense compounds to PG for use in target validation studies in certain therapeutic areas (se...